Adrenal and Cardiovascular Endocrinology

ea0099p1 | Adrenal and Cardiovascular Endocrinology

Reversal of cardiac damage after treatment for aldosterone-producing adenoma and idiopathic hyperaldosteronism – A Prospective Cardiac Magnetic Resonance Imaging study

ea0099p2 | Adrenal and Cardiovascular Endocrinology

Prospective, multi-country, observational study of patients with endogenous Cushing’s syndrome exposed to Ketoconazole (using the existing European Registry on Cushing’s Syndrome (ERCUSYN)), to assess drug use, safety and effectiveness

ea0099p3 | Adrenal and Cardiovascular Endocrinology

Fingerprints of increased susceptibility to adrenal crisis in patients with chronic adrenal insufficiency

ea0099p4 | Adrenal and Cardiovascular Endocrinology

The truth hidden behind a case of resistant hypertension

ea0099p5 | Adrenal and Cardiovascular Endocrinology

A case of a composite pheochromocytoma with a spindle cell sarcoma exhibiting aggressive behavior

ea0099p6 | Adrenal and Cardiovascular Endocrinology

The differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome

ea0099p7 | Adrenal and Cardiovascular Endocrinology

Inflammation-based scores in a large monocentric cohort of adrenocortical carcinoma and adrenocortical adenoma: role of the hormonal secretion pattern

ea0099p8 | Adrenal and Cardiovascular Endocrinology

Enhanced well-being in patients with congenital adrenal hyperplasia on modified-release hydrocortisone compared to conventional glucocorticoid replacement

ea0099p9 | Adrenal and Cardiovascular Endocrinology

Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas

ea0099p10 | Adrenal and Cardiovascular Endocrinology

Nausea and vomiting, a clue for the diagnosis of pheochromocytoma?

ea0099p11 | Adrenal and Cardiovascular Endocrinology

A rare case of testicular adrenal rest tumor associated to X-linked adrenoleukodystrophy

ea0099p12 | Adrenal and Cardiovascular Endocrinology

How to assess adrenal function during low dose prednisolone treatment – impact of a 1- vs 2-day prednisolone pause before the ACTH test: Results from the Double Edge-Rescue Study

ea0099p13 | Adrenal and Cardiovascular Endocrinology

Morning cortisol levels in patients with established primary adrenal insufficiency

ea0099p14 | Adrenal and Cardiovascular Endocrinology

Improved selectivity of adrenal venous sampling with the use of alternative steroids to cortisol

ea0099p15 | Adrenal and Cardiovascular Endocrinology

Dysregulation of salivary cortisol rhythm in non-secreting and mild cortisol-secreting adrenal incidentalomas

ea0099p16 | Adrenal and Cardiovascular Endocrinology

False-positive and false-negative results during screening, confirmatory testing and subtyping for suspected primary aldosteronism: lessons from Prosaldo

ea0099p17 | Adrenal and Cardiovascular Endocrinology

Plasma catestatin and relaxin-2 levels may predict impaired glucose metabolism in patients with primary hypertension

ea0099p18 | Adrenal and Cardiovascular Endocrinology

Clinical, biochemical, histopathological, and metabolic characteristics of patients with pheochromocytomas

ea0099p19 | Adrenal and Cardiovascular Endocrinology

Intra-tissular profile of adrenal steroids reveals variable levels associated with adrenocortical tumors (ACT) differentiation and suggests alterations in steroids export

ea0099p20 | Adrenal and Cardiovascular Endocrinology

Study on the pathogenesis of adrenocortical adenoma with bilateral independent secretion of aldosterone and cortisol: a case report and literature review

ea0099p21 | Adrenal and Cardiovascular Endocrinology

Analysis of salivary dexamethasone does not improve the specificity of the dexamethasone suppression test

ea0099p22 | Adrenal and Cardiovascular Endocrinology

Update on autoimmune polyendocrine syndrome type-1 in Norway: Using longitudinal immune cell composition incorporated with clinical features

ea0099p23 | Adrenal and Cardiovascular Endocrinology

Using basal cortisol cut-off to define adrenal sufficiency in a Southeast Asian population

ea0099p24 | Adrenal and Cardiovascular Endocrinology

Adrenocortical cells are prone to regulated cell death during in vitro septic conditions

ea0099p25 | Adrenal and Cardiovascular Endocrinology

Prevalence and outcome of primary aldosteronism in PBMAH: A single center study and systematic review of the literature

ea0099p26 | Adrenal and Cardiovascular Endocrinology

Towards precision medicine in adrenocortical carcinoma; predicting response to mitotane using proteomics

ea0099p27 | Adrenal and Cardiovascular Endocrinology

Impact on immunophenotype of switching from conventional glucocorticoids to modified-release hydrocortisone in congenital adrenal hyperplasia

ea0099p28 | Adrenal and Cardiovascular Endocrinology

Blood pressure changes during smoking cessation on dulaglutide and placebo treatment – a secondary analysis of the randomized, double-blind, placebo-controlled SKIP trial

ea0099p32 | Adrenal and Cardiovascular Endocrinology

Physical activity after planned cessation of prednisolone treatment in patients with polymyalgia rheumatica and/or giant cell arteritis: baseline data from the double edge-replace study

ea0099p208 | Adrenal and Cardiovascular Endocrinology

Webinars for patient education on congenital adrenal hyperplasia

ea0099p214 | Adrenal and Cardiovascular Endocrinology

Impact of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1

ea0099p215 | Adrenal and Cardiovascular Endocrinology

Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody)

ea0099p216 | Adrenal and Cardiovascular Endocrinology

Psychotropic drugs in patients with Addison’s disease: A Swedish population-based cohort study

ea0099p217 | Adrenal and Cardiovascular Endocrinology

Brown adipose tissue activation on 18FDG-PET/CT scan in phaeochromocytoma: A case series

ea0099p218 | Adrenal and Cardiovascular Endocrinology

Severe hyponatraemia and hyperkalaemia in pre-eclampsia due to hypoadrenalism/functional hypoadrenalism

ea0099p219 | Adrenal and Cardiovascular Endocrinology

11β-hydroxysteroid dehydrogenase type 1 inhibition unmasks multiple pathways that may mitigate the adverse effects of prescribed prednisolone

ea0099p220 | Adrenal and Cardiovascular Endocrinology

Adrenalectomy improves blood pressure and insulin secretion in adrenal incidentalomas and MACS

ea0099p221 | Adrenal and Cardiovascular Endocrinology

Constitutional duplication of PRKACA gene is a cause of isolated primary pigmented nodular adrenocortical disease (PPNAD)

ea0099p222 | Adrenal and Cardiovascular Endocrinology

Lysophosphatidylcholines and acylcarnitines: Novel markers of physiological glucocorticoid action in adipose tissue

ea0099p223 | Adrenal and Cardiovascular Endocrinology

Medication-associated false positive results for plasma normetanephrine, metanephrine and methoxytyramine

ea0099p224 | Adrenal and Cardiovascular Endocrinology

Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism

ea0099p225 | Adrenal and Cardiovascular Endocrinology

Baseline characteristics of children and adolescents with classic congenital adrenal hyperplasia enrolled in CAHtalyst pediatric, a phase 3 Study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist

ea0099p226 | Adrenal and Cardiovascular Endocrinology

Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma

ea0099p227 | Adrenal and Cardiovascular Endocrinology

CXCR4-directed [68Ga]Ga-PentixaFor PET/CT as a diagnostic modality in subtyping primary aldosteronism

ea0099p228 | Adrenal and Cardiovascular Endocrinology

Impact of glucocorticoid-induced adrenal insufficiency on health-related quality of life in patients receiving long-term low dose prednisolone treatment: Results from the double edge-rescue trial

ea0099p229 | Adrenal and Cardiovascular Endocrinology

Benefits and harms according to intensity of statin therapy in Korean patients with dyslipidemia

ea0099p230 | Adrenal and Cardiovascular Endocrinology

Description of recreational male and female athletes illicitly using androgenic anabolic steroids

ea0099p231 | Adrenal and Cardiovascular Endocrinology

3D printed, personalized cortisol for cortisol deficiencies

ea0099p232 | Adrenal and Cardiovascular Endocrinology

Prevalence and treatment of osteoporosis and bone fractures in Cushing’s syndrome across Europe

ea0099p233 | Adrenal and Cardiovascular Endocrinology

Decoding adrenal marginal zone lymphoma’s silent narrative

ea0099p234 | Adrenal and Cardiovascular Endocrinology

Fine needle aspiration cytology of adrenal lesions: A 22-year single center experience

ea0099p235 | Adrenal and Cardiovascular Endocrinology

SIAH1, a regulator of the Wnt/β-catenin pathway in human adrenocortical cells

ea0099p236 | Adrenal and Cardiovascular Endocrinology

Impact of environmental pollution on adrenocortical carcinoma in Italy

ea0099p237 | Adrenal and Cardiovascular Endocrinology

Fertility outcomes in women with classic and non-classic congenital adrenal hyperplasia on modified-release hydrocortisone (MR-HC)

ea0099p238 | Adrenal and Cardiovascular Endocrinology

Musculoskeletal health and body composition in patients discontinuing long-term prednisolone treatment – prospective data from the replace Study

ea0099p239 | Adrenal and Cardiovascular Endocrinology

Peripheral cortisol concentration during adrenal vein sampling for primary aldosteronism

ea0099p240 | Adrenal and Cardiovascular Endocrinology

Management of Giant Pheochromocytomas: A single tertiary center experience

ea0099p241 | Adrenal and Cardiovascular Endocrinology

Treatment outcomes in patients with recurrent adrenocortical carcinoma

ea0099p242 | Adrenal and Cardiovascular Endocrinology

Congenital adrenal hyperplasia and myelolipomas: A case report

ea0099p243 | Adrenal and Cardiovascular Endocrinology

Does 177Lu-DOTA-TATE works in metastatic cardiac paraganglioma?

ea0099p244 | Adrenal and Cardiovascular Endocrinology

Cardiovascular risk in patients with primary hyperparathyroidism

ea0099p412 | Adrenal and Cardiovascular Endocrinology

β-estradiol contributes to sex differences in resilience to septic-induced cardiacdysfunction via GPER-1/PPARδ/NLRP3 signaling

ea0099p413 | Adrenal and Cardiovascular Endocrinology

Glucocorticoid-induced adrenal insufficiency in patients with polymyalgia rheumatica and giant cell arteritis during long-term low-dose prednisolone treatment: Prediction based on indicators of exogenous hypercortisolism in the Double Edge Study

ea0099p414 | Adrenal and Cardiovascular Endocrinology

Aldosterone:metanephrine ratio better predicts laterality in patients with primary aldosteronism and mild autonomous cortisol co-secretion than aldosterone:cortisol ratio

ea0099p415 | Adrenal and Cardiovascular Endocrinology

Bilateral adrenal haemorrhage secondary to heparin induced thrombocytopenia- a rare cause and presentation of adrenal crisis

ea0099p416 | Adrenal and Cardiovascular Endocrinology

Increased cardiovascular risk in patients with germline VHL gene alterations – a UKBIOBANK-based genomic study

ea0099p417 | Adrenal and Cardiovascular Endocrinology

Germline targeted next-generation sequencing in patients with adrenal incidentalomas

ea0099p418 | Adrenal and Cardiovascular Endocrinology

Appraisal of modified tests for the diagnosis and treatment of primary aldosteronism: A single endocrine center experience

ea0099p419 | Adrenal and Cardiovascular Endocrinology

Primary aldosteronism: Small molecule antagonists of mutant KCNJ5 potassium channels

ea0099p420 | Adrenal and Cardiovascular Endocrinology

Different metabolic pathways associated with total cortisol exposure and the cortisol time profile: A randomized cross-over clinical trial

ea0099p421 | Adrenal and Cardiovascular Endocrinology

A case of reversible Brugada syndrome with severe hypothyroidism

ea0099p422 | Adrenal and Cardiovascular Endocrinology

Undertreated and undiagnosed adrenal insufficiency as a premature cause of death in glucocorticoid users

ea0099p423 | Adrenal and Cardiovascular Endocrinology

Baseline characteristics of adults with classic congenital adrenal hyperplasia enrolled in CAHtalyst, a phase 3 study of Crinecerfont, a corticotropin-releasing factor type 1 receptor antagonist

ea0099p424 | Adrenal and Cardiovascular Endocrinology

Diagnostic performance of dehydroepiandrosterone sulfate in predicting adrenal insufficiency

ea0099p425 | Adrenal and Cardiovascular Endocrinology

Income and work loss in patients with Addison’s disease in Sweden: A nationwide population-based study

ea0099p426 | Adrenal and Cardiovascular Endocrinology

Evaluation of quality of life by AddiQoL-30 compared to SF-36 in patients with previous long-term prednisolone treatment

ea0099p427 | Adrenal and Cardiovascular Endocrinology

First report of inclisiran utilization for hypercholesterolemia treatment in real-world clinical settings in a middle east population

ea0099p428 | Adrenal and Cardiovascular Endocrinology

Development and validation of LC–MS/MS assay for simultaneous determination of thirteen steroid hormones and two synthetic steroids in saliva: potential utility for pediatric population and beyond

ea0099p429 | Adrenal and Cardiovascular Endocrinology

Establishing cut-off values for late-night salivary cortisol and cortisone measured by LC–MS/MS in the diagnosis of endogenous hypercortisolism

ea0099p430 | Adrenal and Cardiovascular Endocrinology

Holistic nursing care in acromegaly: A case report

ea0099p431 | Adrenal and Cardiovascular Endocrinology

Cognitive functions in patients with mild autonomous cortisol secretion: Is it related with the serum brain-derived neurotrophic factor level?

ea0099p432 | Adrenal and Cardiovascular Endocrinology

Role of ccfDNA-based biomarkers in classification of adrenocortical adenomas

ea0099p433 | Adrenal and Cardiovascular Endocrinology

Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism

ea0099p434 | Adrenal and Cardiovascular Endocrinology

Even a nonfunctional adrenal incidentaloma carries a higher metabolic disease risk: Cross-sectional controlled study

ea0099p435 | Adrenal and Cardiovascular Endocrinology

Performance of plasma cortisol at 1600 hours for the diagnosis of Cushing syndrome

ea0099p436 | Adrenal and Cardiovascular Endocrinology

Different modes of cell death induced by chemotherapeutic agents in treatment resistant and sensitive models of adrenocortical carcinoma

ea0099p437 | Adrenal and Cardiovascular Endocrinology

Adrenocortical activity in patients with vasovagal syncope

ea0099p438 | Adrenal and Cardiovascular Endocrinology

A service review of phaeochromocytoma management at the regional adrenal referral centre

ea0099p439 | Adrenal and Cardiovascular Endocrinology

NFAT and risk of dementia

ea0099p440 | Adrenal and Cardiovascular Endocrinology

The challenges of adrenal incidentaloma evaluation in dialysis patients

ea0099p441 | Adrenal and Cardiovascular Endocrinology

Association between endothelial dysfunction and androgen levels in men with coronary artery disease

ea0099p442 | Adrenal and Cardiovascular Endocrinology

26th European Congress of Endocrinology

BiosciAbstracts